Tuğba Güven özkan, Ph.D.
About Tuğba Güven özkan, Ph.D.
Tuğba Güven Özkan, Ph.D., is a Principal Scientist and Group Lead at Asklepios BioPharmaceutical, Inc. She has extensive experience in molecular biology and genetics, particularly in AAV gene therapy, and has held various research positions in notable institutions.
Work at Asklepios BioPharmaceutical
Tuğba Güven özkan, Ph.D., currently serves as Principal Scientist and Group Lead at Asklepios BioPharmaceutical, Inc. (AskBio) in Philadelphia, Pennsylvania. She transitioned to this role in 2023 after working as a Senior Scientist at the same organization from 2021 to 2023 in Durham, North Carolina. In her current position, she leads a team focused on advancing AAV Gene Therapy, leveraging her extensive expertise in molecular biology and genetics.
Previous Experience at SwanBio Therapeutics
Prior to her current role, özkan worked as a Senior Research Scientist at SwanBio Therapeutics from 2019 to 2021 in the Greater Philadelphia Area. During her tenure, she contributed to the design and engineering of transformative medicines, collaborating with various teams to enhance research outcomes.
Research Role at The Scripps Research Institute
From 2010 to 2018, özkan was a Research Associate at The Scripps Research Institute in Jupiter, Florida. In this role, she engaged in significant research projects that advanced the understanding of molecular biology and genetics, further solidifying her expertise in the field.
Education and Expertise
Tuğba Güven özkan holds a Ph.D. in Genetics and Development from UT Southwestern Medical Center, where she studied from 2004 to 2009. She also earned a B.S. in Molecular Biology and Genetics from Bilkent University, completing her studies from 1999 to 2004. In addition, she achieved a Nanodegree in Programming for Data Science from Udacity in 2019, enhancing her technical skills relevant to her research.
Background in Molecular Biology and Genetics
özkan has a strong background in molecular biology and genetics, which plays a crucial role in her contributions to AAV Gene Therapy. Her academic and professional experiences have equipped her with the necessary skills to lead research initiatives and collaborate effectively across multidisciplinary teams.